Crescent Sterling’s Eli Lilly LLY Stock Holding History

Crescent Sterling’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$481K	Buy	416 +32	+8%	+$37.8K	0.4%	59
2026 Q2	$461K	Buy	384 +14	+4%	+$14.3K	0.41%	59
2026 Q1	$340K	Sell	370 -10	-3%	-$10.1K	0.33%	64
2025 Q4	$408K	Sell	380 -25	-6%	-$23.9K	0.42%	57
2025 Q3	$309K	Sell	405 -148	-27%	-$110K	0.33%	61
2025 Q2	$431K	Hold	553	–	–	0.48%	54
2025 Q1	$457K	Hold	553	–	–	0.47%	51
2024 Q4	$427K	Sell	553 -72	-12%	-$59.6K	0.44%	53
2024 Q3	$554K	Hold	625	–	–	0.53%	50
2024 Q2	$566K	Sell	625 -124	-17%	-$99.2K	0.54%	51
2024 Q1	$583K	Sell	749 -15	-2%	-$10.7K	0.53%	47
2023 Q4	$445K	Buy	764 +6	+0.8%	+$3.5K	0.44%	51
2023 Q3	$407K	Buy	758 +184	+32%	+$94.8K	0.43%	52
2023 Q2	$269K	Buy	+574	New	+$241K	0.26%	65
2023 Q1	–	Sell	-563	Closed	-$206K	–	76
2022 Q4	$206K	Buy	+563	New	+$200K	0.22%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Crescent Sterling's LLY Position: Q3 2026 in Review

Crescent Sterling increased its Eli Lilly (LLY) stake by 8.3% in Q3 2026, buying an estimated $37.8K and bringing the position to 416 shares worth $481K. The position accounts for 0.4% of the portfolio, ranked #59.

Crescent Sterling first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $583K in Q1 2024. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Crescent Sterling held 416 shares of Eli Lilly worth $481K as of Q3 2026.
Crescent Sterling bought 32 Eli Lilly shares in Q3 2026, an estimated $37.8K.
Eli Lilly made up 0.4% of Crescent Sterling's portfolio in Q3 2026, its #59 holding.
Crescent Sterling first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
Crescent Sterling's Eli Lilly position peaked at $583K in Q1 2024.
1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Crescent Sterling's 13F filing for Q3 2026, filed 16 Oct 2026.